OakChart

Natural Alternatives International Inc

NAIIConsumer Defensive·Packaged Foods·USA·Nano·NASD·Nov 11 • 3:59 PM ET

1.03+0.03 (3.10%)
2026-11-11 22:20 CET
Market cap
6.27 USD m
Revenue, TTM
141.35 USD m
Net income, TTM
-20.70 USD m
Free cash flow, TTM
-12.62 USD m
EPS diluted, TTM
-3.42
P/E
-
Compare

Price

NAII against its 20, 50 and 200-day averages
2050200
1.002.003.00674K1.3MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NAIIclose 1.0320-day 1.1250-day 1.46200-day 2.321.03

79.2% under the 52-week high of 4.96 on 13 Jan 2026. 52-week low 0.94 on 11 Nov 2026. Last 15 sessions, 29.2% high to low

Volume 0.64× normal · the line is the 50-bar volume average

Profile

NAII
52-week range, 1% of the way up
1.004.96

Natural Alternatives International, Inc. engages in the manufacturing, distribution, and marketing of nutritional supplements and other health care products. It operates through the Private-Label Contract Manufacturing, and Patent and Trademark Licensing segments. The Private-Label Contract Manufacturing segment provides manufacturing services to companies that market and distribute nutritional supplements and other health care products. The Patent and Trademark Licensing segment is involved in direct raw material sales and royalty income from license and supply agreements associated with the sale and use of beta-alanine. The company was founded by Mark A. LeDoux in 1980 and is headquartered in Carlsbad, CA.

Employees230
IPOJan 05, 1990
Beta0.43
ATR, 14d0.10
Rel volume0.64
Short float0.10%
Insider own17.90%
Inst own36.25%

Snapshot

6 groups

Valuation

Index-
Market Cap6.46M
Enterprise Value48.96M
Income-20.70M
Sales141.35M
Book/sh7.97
Cash/sh1.19
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees230
IPOJan 05, 1990

Ratios

P/E-
Forward P/E-
PEG-
P/S0.05
P/B0.13
P/C0.87
P/FCF-
EV/EBITDA-
EV/Sales0.35
Quick Ratio0.92
Current Ratio1.73
Debt/Eq1.00
LT Debt/Eq0.78
Option/ShortNo / Yes

Earnings

EPS (ttm)-3.42
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y- -
Sales past 3/5Y-3.44% -4.56%
EPS Y/Y TTM-52.59%
Sales Y/Y TTM9.08%
EPS Q/Q-90.95%
Sales Q/Q1.48%
EarningsSep 28 AMC
EPS/Sales Surpr.- -

Ownership

Insider Own17.90%
Insider Trans0.00%
Inst Own36.25%
Inst Trans2.23%
ROA-13.47%
ROE-34.96%
ROIC-23.32%
Gross Margin5.54%
Oper. Margin-6.41%
Profit Margin-14.64%
SMA20-8.18%
SMA50-29.41%
SMA200-55.62%
Trades-

Technical

Shs Outstand6.27M
Shs Float5.15M
Short Float0.10%
Short Ratio0.13
Short Interest0.01M
52W High4.96 -79.23%
52W Low1.00 3.10%
Volatility7.92% 6.36%
ATR (14)0.10
RSI (14)32.55
Beta0.43
Rel Volume0.64
Avg Volume42.19K
Volume27,077

Performance

Perf Week-6.36%
Perf Month-10.43%
Perf Quarter-52.53%
Perf Half Y-61.99%
Perf YTD-71.23%
Perf Year-63.99%
Perf 3Y-83.98%
Perf 5Y-92.84%
Perf 10Y-91.23%
Recom-
Target Price-
Prev Close1.00
Price1.03
Change %3.10%

Peers

Mkt cap
TickerCompanyMkt cap
BHSTBioHarvest Sciences Inc39.67M
FTLFFitLife Brands Inc76.53M
NATRNature's Sunshine Products Inc178.66M
LFVNLifevantage Corp59.86M
USNAUsana Health Sciences Inc237.42M
MTEXMannatech Inc16.54M
HLFHerbalife Ltd1.63B
PREPrenetics Global Limited298.78M
NHTCNatural Health Trends Corp6.80M
BCPCBalchem Corp5.51B

Insider trading

14 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
LEDOUX MARK ACEO/ChairmanMar 06 '26Buy2.805321,490160,221Mar 06 07:36 PM
LEDOUX MARK ACEO/ChairmanMar 04 '26Buy2.775001,385159,471Mar 06 07:36 PM
LEDOUX MARK ACEO/ChairmanMar 05 '26Buy2.75218600159,689Mar 06 07:36 PM
LEDOUX MARK ACEO/ChairmanFeb 27 '26Buy2.855001,425158,471Mar 03 07:23 PM
LEDOUX MARK ACEO/ChairmanMar 02 '26Buy2.795001,395158,971Mar 03 07:23 PM
LEDOUX MARK ACEO/ChairmanFeb 26 '26Buy2.855001,423157,721Feb 27 05:18 PM
LEDOUX MARK ACEO/ChairmanFeb 25 '26Buy2.815001,405157,221Feb 27 05:18 PM
LEDOUX MARK ACEO/ChairmanFeb 27 '26Buy2.80250700157,971Feb 27 05:18 PM
LEDOUX MARK ACEO/ChairmanFeb 24 '26Buy2.711,0002,710156,971Feb 24 09:17 PM
LEDOUX MARK ACEO/ChairmanFeb 23 '26Buy2.707502,025155,971Feb 24 09:17 PM
LEDOUX MARK ACEO/ChairmanFeb 20 '26Buy2.65250664155,221Feb 24 09:17 PM
LEDOUX MARK ACEO/ChairmanFeb 17 '26Buy2.602,5006,490152,721Feb 20 06:05 PM
LEDOUX MARK ACEO/ChairmanFeb 19 '26Buy2.561,5003,833154,721Feb 20 06:05 PM
LEDOUX MARK ACEO/ChairmanFeb 18 '26Buy2.565001,282153,221Feb 20 06:05 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.52B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
BSVOEA Bridgeway Omni Small-Cap Value ETFAUM: 2.44B
DFACU.S. Core Equity 2 Portfolio-ETF Class SharesAUM: 49.14B
DCORUS Core Equity 1 Portfolio ETF Class SharesAUM: 3.65B
DXUVUS Vector Equity Portfolio ETF Class SharesAUM: 665.71M
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
No quarterly earnings.

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2010FY0.560-0.58065.55-

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
No estimate revisions.

Estimate history

EPS, annual0.730.922-0.2461.6881.740.429-1.229-2.283-3.433
Period201820192020202120222023202420252026
EPS, quarterly-0.317-0.335-0.37-0.368-1.168-0.048-0.425-0.716-2.23
PeriodQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Sales, annual129.837137.09116.176178.52167.966157.023113.849129.582141.353
Period201820192020202120222023202420252026
Sales, quarterly29.48833.20833.97328.67533.72637.32934.50435.29534.225
PeriodQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Shares, annual7.5587.2256.7526.4376.136.0746.26.1786.267
Period201820192020202120222023202420252026
Shares, quarterly6.26.1996.1996.1796.1786.1776.1776.2756.267
PeriodQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26

Income statement, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue141.35141.35129.58113.85157.02167.97178.52116.18137.09
Cost of Goods Sold Incl. D&A133.52133.52120.57106.93142.94147.37155.84106.74118.18
Gross Profit7.837.839.016.9214.0920.5922.689.4418.91
Selling, General and Administrative Excl. Other16.9016.9016.1515.204.749.727.8111.6511.75
Research and Development-2.301.801.902.102.501.901.801.80
Other Operating Expense0.000.000.000.001.420.000.000.000.00
Operating Income-9.06-9.06-7.14-8.287.9210.8814.87-2.217.16
Interest Expense1.191.190.920.360.450.080.120.070.00
Unusual Expense10.8510.851.800.200.200.201.202.002.40
Net Income Before Taxes-20.27-20.27-10.74-9.463.5613.6612.12-1.747.95
Income Taxes0.430.432.83-2.251.032.951.36-0.091.41
Consolidated Net Income-20.70-20.70-13.57-7.222.5210.7110.77-1.656.54
Net Income From Continuing Operations-20.70-20.70-13.57-7.222.5210.7110.77-1.656.54
Net Income-20.70-20.70-13.57-7.222.5210.7110.77-1.656.54
EPS (Recurring)-2.16-2.17-2.07-1.210.451.761.82-0.041.16
EPS (Basic, Before Extraordinaries)-3.42-3.43-2.28-1.230.431.751.71-0.250.96
EPS (Diluted)-3.42-3.43-2.28-1.230.431.741.69-0.250.92
EBITDA-4.35-4.35-2.58-3.6315.0017.7922.634.5210.63
Non-Operating Income (Expense)0.830.83-0.89-0.62-3.713.06-1.432.543.19
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.460.480.770.950.800.761.041.251.28
Price To Earnings Ratio----16.975.9910.02-8.58
Price To Sales Ratio0.100.100.150.310.270.380.600.390.60
Gross Margin5.545.546.956.088.9712.2612.718.1313.79
Operating Margin-6.41-6.41-5.51-7.275.046.488.33-1.905.22
Net Margin-14.64-14.64-10.48-6.341.616.386.03-1.424.77
Shares Outstanding6.276.276.186.206.076.136.446.757.23
Market Capitalization6.276.2720.2737.3343.7664.21108.0346.4387.72

Income statement, quarterly

Currency USD, millions
Metric2026Q42026Q32026Q22026Q12025Q42025Q32025Q22025Q1
Total Revenue34.2335.3034.5037.3333.7328.6833.9733.21
Cost of Goods Sold Incl. D&A32.7835.1032.3033.3330.3326.9432.4130.89
Gross Profit1.440.202.204.003.401.741.562.32
Selling, General and Administrative Excl. Other4.354.304.244.013.983.934.353.90
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-2.90-4.10-2.04-0.02-0.58-2.19-2.79-1.58
Interest Expense0.470.270.220.230.210.250.280.18
Unusual Expense10.550.100.100.101.500.000.100.20
Net Income Before Taxes-13.49-4.24-2.33-0.20-2.82-2.64-2.87-2.41
Income Taxes0.050.070.220.094.40-0.46-0.68-0.43
Consolidated Net Income-13.54-4.31-2.55-0.29-7.22-2.19-2.19-1.98
Net Income From Continuing Operations-13.54-4.31-2.55-0.29-7.22-2.19-2.19-1.98
Net Income-13.54-4.31-2.55-0.29-7.22-2.19-2.19-1.98
EPS (Recurring)-1.01-0.70-0.41-0.04-1.00-0.37-0.36-0.31
EPS (Basic, Before Extraordinaries)-2.23-0.72-0.42-0.05-1.17-0.37-0.37-0.33
EPS (Diluted)-2.23-0.72-0.42-0.05-1.17-0.37-0.37-0.33
EBITDA-1.72-2.90-0.871.150.58-1.09-1.65-0.45
Non-Operating Income (Expense)0.430.230.030.14-0.52-0.200.30-0.46
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.080.080.160.140.140.160.300.24
Price To Sales Ratio0.100.110.160.130.160.160.210.30
Gross Margin4.220.566.3810.7010.076.054.606.98
Operating Margin-8.49-11.62-5.91-0.05-1.73-7.64-8.20-4.75
Net Margin-39.56-12.21-7.40-0.78-21.40-7.62-6.45-5.97
Shares Outstanding6.276.286.186.186.186.186.206.20
Market Capitalization6.2716.2422.1117.6320.2721.3226.7235.53

Balance sheet, annual

Currency USD, millions
Metric2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments7.4712.3211.9813.6021.8332.1330.4825.0423.61
Short Term Receivables20.6514.9216.897.3317.4919.0417.8516.8616.12
Inventories30.7524.8724.2529.6932.4827.0127.9726.0023.57
Other Current Assets6.567.168.496.384.952.172.733.481.88
Total Current Assets65.4359.2861.6157.0176.7580.3579.0271.3965.18
Net Property, Plant & Equipment59.6791.9495.7574.2166.2738.1539.8821.0919.29
Total Investments and Advances0.000.000.080.000.000.000.000.310.00
Deferred Tax Assets14.5714.3512.560.350.000.210.201.821.32
Other Assets1.340.721.742.582.981.571.110.710.73
Total Assets141.02166.29171.74134.15146.00120.28120.2095.3186.53
Short Term Debt Incl. Current Port. of LT Debt11.204.434.892.760.300.0010.000.000.00
Accounts Payable18.1515.3512.747.7816.1811.8912.518.639.65
Income Tax Payable-0.410.510.370.170.621.011.220.79
Other Current Liabilities8.378.615.334.976.609.564.294.403.84
Total Current Liabilities37.7228.8023.4615.8823.2622.0727.8114.2514.28
Long Term Debt38.7754.6055.4028.1731.5416.4818.780.000.00
Provision for Risks Charges0.000.110.140.340.340.390.700.250.04
Deferred Tax Liabilities14.5714.359.39-1.22--2.831.86
Other Liabilities0.000.000.740.991.121.251.541.892.10
Total Liabilities91.0697.8689.1445.3857.4840.2048.8319.2218.28
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity49.9668.4382.5988.7788.5280.0871.3876.0868.25
Total Shareholders Equity49.9668.4382.5988.7788.5280.0871.3876.0868.25
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity49.9668.4382.5988.7788.5280.0871.3876.0868.25
Total Liabilities & Stockholders Equity141.02166.29171.74134.15146.00120.28120.2095.3186.53
Book Value Per Share7.9711.0813.3214.6214.4412.4410.5710.539.03
Tangible Book Value Per Share7.9711.0813.3214.6214.4412.4410.5710.539.03
Full-Time Employees230234310241294228184186246
Price to Book Ratio0.130.260.440.490.721.350.651.101.22
Return on Assets-13.47-8.03-4.721.808.058.96-1.537.196.35
Return on Equity-34.96-17.98-8.422.8512.7114.22-2.239.067.81
Return on Invested Capital-23.32-11.03-5.232.168.9211.15-1.828.607.40
Quick Ratio0.921.191.591.721.902.421.843.182.91
Current Ratio1.732.062.633.593.303.642.845.014.56

Cash flow, annual

Currency USD, millions
MetricTTM2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-20.70-20.70-13.57-7.222.5210.7110.77-1.656.54
Depreciation4.714.714.564.657.086.917.766.733.46
Other Funds (Non Cash)16.2516.259.767.33-0.380.921.415.131.86
Funds from Operations0.270.274.361.858.2519.3019.739.3212.08
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-9.19-9.191.57-3.35-1.23-7.431.08-5.63-5.52
Income Taxes Payable-0.14-0.14-1.110.19-0.170.45-0.74-0.16-0.67
Cash from Operating Activities-8.92-8.925.93-1.507.0211.8720.813.696.56
Capital Expenditures-3.70-3.70-3.61-3.02-13.52-26.49-5.11-4.54-5.33
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.060.030.070.040.02
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.001.50
Cash from Investing Activities-3.70-3.70-3.61-3.02-13.47-26.46-5.04-4.51-3.81
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-0.09-0.09-0.18-0.22-1.50-5.50-4.11-3.75-1.33
Repurchase of Common Pref Stock-0.09-0.09-0.18-0.22-1.50-5.50-4.15-3.75-1.37
Sale of Common Pref Stock0.000.000.000.000.000.000.040.000.04
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.04
Issuance or Reduction of Debt, Net7.867.86-1.803.11-0.289.79-10.0010.000.00
Change in Long Term Debt2.012.01-0.30-0.29-0.289.790.000.000.00
Issuance of Long Term Debt11.0011.000.000.000.0010.000.000.000.00
Reduction of Long Term Debt-8.99-8.99-0.30-0.29-0.28-0.200.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities7.777.77-1.972.89-1.784.29-14.116.25-1.33
Net Change in Cash-4.85-4.850.34-1.62-8.23-10.301.665.441.43
Free Cash Flow-12.62-12.622.32-4.51-6.50-14.6215.70-0.851.24
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow--8.41---6.84-66.90
Deferred Taxes & Investment Tax Credit-0.003.61-2.91-0.970.75-0.21-0.890.21

Balance sheet, quarterly

Currency USD, millions
Metric2026Q42026Q32026Q22026Q12025Q42025Q3
Cash & Short Term Investments7.479.203.757.7412.3210.61
Short Term Receivables20.6520.6617.8819.1014.9213.01
Inventories30.7529.9333.4330.6524.8726.99
Other Current Assets6.564.216.457.567.167.91
Total Current Assets65.4363.9961.5265.0559.2858.52
Net Property, Plant & Equipment59.6789.9491.0491.2191.9492.25
Total Investments and Advances0.000.000.000.000.000.00
Deferred Tax Assets14.57---14.353.24
Other Assets1.340.940.750.690.720.94
Total Assets141.02154.88153.30156.94166.29154.94
Short Term Debt Incl. Current Port. of LT Debt11.2012.678.445.034.434.32
Accounts Payable18.1518.1616.5520.0915.3512.82
Income Tax Payable-0.000.000.000.410.00
Other Current Liabilities8.378.307.878.788.616.17
Total Current Liabilities37.7239.1232.8533.9028.8023.31
Long Term Debt38.7752.5053.2753.9054.6054.11
Provision for Risks Charges0.000.150.140.120.110.16
Deferred Tax Liabilities14.57---14.35-
Other Liabilities0.000.000.000.000.000.74
Total Liabilities91.0691.7786.2587.9297.8678.33
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity49.9663.1167.0569.0268.4376.62
Total Shareholders Equity49.9663.1167.0569.0268.4376.62
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity49.9663.1167.0569.0268.4376.62
Total Liabilities & Stockholders Equity141.02154.88153.30156.94166.29154.94
Book Value Per Share7.9710.0610.8511.1711.0812.40
Tangible Book Value Per Share7.9710.0610.8511.1711.0812.40
Full-Time Employees230---234-
Price to Book Ratio0.130.240.320.260.260.27
Return on Assets-13.47-9.28-7.92-7.47-8.03-5.34
Return on Equity-34.96-20.57-16.75-15.93-17.98-10.25
Return on Invested Capital-15.26-3.73-2.12-0.24-5.87-1.67
Quick Ratio0.920.870.851.011.191.35
Current Ratio1.731.641.871.922.062.51

Cash flow, quarterly

Currency USD, millions
Metric2026Q42026Q32026Q22026Q12025Q42025Q3
Net Income-13.54-4.31-2.55-0.29-7.22-2.19
Depreciation1.181.191.171.171.161.14
Other Funds (Non Cash)11.801.371.591.504.291.30
Funds from Operations-0.56-1.750.202.371.850.25
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.514.25-6.53-6.391.505.74
Income Taxes Payable0.070.050.07-0.320.75-0.43
Cash from Operating Activities-1.072.50-6.33-4.023.355.99
Capital Expenditures-0.64-1.10-0.93-1.03-1.46-0.80
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.64-1.10-0.93-1.03-1.46-0.80
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-0.00-0.080.00-0.01-0.00-0.17
Repurchase of Common Pref Stock-0.00-0.080.00-0.01-0.00-0.17
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-0.024.123.270.48-0.17-3.08
Change in Long Term Debt2.23-0.08-0.08-0.07-0.07-0.07
Issuance of Long Term Debt11.000.000.000.000.000.00
Reduction of Long Term Debt-8.77-0.08-0.08-0.07-0.07-0.07
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-0.024.043.270.47-0.18-3.24
Net Change in Cash-1.725.44-3.99-4.581.711.95
Free Cash Flow-1.701.40-7.26-5.051.895.19
Price to Free Cash Flow---16.998.74-

Revenue breakdown

Non-US2025: 50.73M 2026: 49.19M
United States2025: 79.13M 2026: 93.32M
Patent and Trademark Licensing2025: 8.08M 2026: 7.90M
Private Label Contract Manufacturing2025: 121.78M 2026: 134.62M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.10%0.0M5.2M41.88K
2026-10-150.08%0.0M5.2M41.46K
2026-09-300.13%0.0M5.2M38.33K
2026-09-150.26%0.0M5.2M42.31K
2026-08-310.14%0.0M5.2M42.71K
2026-08-140.48%0.0M5.2M41.37K
2026-07-310.50%0.0M5.2M20.41K
2026-07-150.18%0.0M5.1M22.26K
2026-06-300.13%0.0M5.1M23.07K
2026-06-150.05%0.0M5.1M22.85K
2026-05-290.09%0.0M5.1M22.72K
2026-05-150.03%0.0M5.1M24.32K
2026-04-300.07%0.0M5.0M25.98K
2026-04-150.10%0.0M5.0M23.89K
2026-03-310.22%0.0M4.9M23.59K
2026-03-130.08%0.0M4.9M18.44K
2026-02-270.11%0.0M4.9M18.41K
2026-02-130.03%0.0M4.9M19.19K
2026-01-300.04%0.0M4.9M21.55K
2026-01-150.25%0.0M4.9M26.42K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-23DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-12-11SEC
2026-09-2810-KAnnual report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-05-21S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-05-1910-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-18NT 10-Q2026-03-31SEC
2026-05-018-KCurrent report2026-04-28SEC
2026-03-208-KCurrent report2026-03-18SEC
2026-03-104Statement of changes in beneficial ownership of securities2026-03-06SEC
2026-03-104Statement of changes in beneficial ownership of securities2026-03-06SEC
2026-03-104Statement of changes in beneficial ownership of securities2026-03-06SEC
2026-03-104Statement of changes in beneficial ownership of securities2026-03-06SEC
2026-03-104Statement of changes in beneficial ownership of securities2026-03-06SEC
2026-03-104Statement of changes in beneficial ownership of securities2026-03-06SEC
2026-03-064Statement of changes in beneficial ownership of securities2026-03-04SEC
2026-03-034Statement of changes in beneficial ownership of securities2026-02-27SEC
2026-02-274Statement of changes in beneficial ownership of securities2026-02-25SEC
2026-02-244Statement of changes in beneficial ownership of securities2026-02-20SEC
2026-02-204Statement of changes in beneficial ownership of securities2026-02-17SEC
2026-02-1310-QQuarterly report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-01-21SCHEDULE 13G/ASEC
2026-01-054Statement of changes in beneficial ownership of securities2025-12-23SEC
2025-12-178-KCurrent report2025-12-17SEC
2025-12-128-KCurrent report2025-12-05SEC
2025-11-1210-QQuarterly report pursuant to Section 13 or 15(d)2025-09-30SEC
2025-10-23DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342025-12-05SEC
2025-09-2310-KAnnual report pursuant to Section 13 or 15(d)2025-06-30SEC
2025-07-218-KCurrent report2025-07-16SEC
2025-07-018-KCurrent report2025-06-27SEC
2025-06-238-KCurrent report2025-06-20SEC
2025-05-1410-QQuarterly report pursuant to Section 13 or 15(d)2025-03-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-034.87K400
2026-0221.96K1000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
CALDWELL SUTTER CAPITAL, INC.7.94%
DIMENSIONAL FUND ADVISORS LP5.35%
MORGAN STANLEY4.90%
Mink Brook Asset Management LLC4.68%
RENAISSANCE TECHNOLOGIES LLC4.42%
VANGUARD CAPITAL MANAGEMENT LLC3.36%
CITADEL ADVISORS LLC1.21%
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.98%
Integrated Wealth Concepts LLC0.70%
GEODE CAPITAL MANAGEMENT, LLC0.68%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.53%
U.S. SMALL CAP VALUE PORTFOLIO2.26%
U.S. MICRO CAP PORTFOLIO1.07%
VANGUARD EXTENDED MARKET INDEX FUND0.83%
U.S. SMALL CAP PORTFOLIO0.41%
EA Bridgeway Omni Small-Cap Value ETF0.40%
Fidelity Extended Market Index Fund0.33%
Omni Small-Cap Value Fund0.29%
Ultra-Small Company Market Fund0.28%
Dimensional U.S. Small Cap ETF0.27%

OakChart. NAII. Cached 15 minutes.

Some panels did not load: ratings.